Watchlist Price Alert

Annovis Bio Inc. (ANVS)

NYSE: ANVS · Real-Time Price · USD

2.83

0.02 (0.71%)

At close: Jun 16, 2025, 10:12 AM

Annovis Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	10.55M	5.75M	28.38M	45.69M	8.07M	1.86K	35.31K	347.47K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	369.6K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	735.08K	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	-745.64M	n/a	n/a
Other Current Assets	n/a	20.8K	n/a	9.87K	6.44K	n/a	n/a	n/a
Total Current Assets	13.93M	10.21M	36.02M	46M	8.12M	747.51K	50.99K	357.96K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	n/a	369.6K	n/a	n/a
Total Assets	13.93M	10.21M	36.02M	46M	8.12M	1.12M	50.99K	357.96K
Account Payables	2.31M	1.29M	3.96M	688.07K	341.86K	1.23M	68.42K	71.11K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.21M	0.00	3.18M	n/a	220.03K	645.34K	477.88K	415.35K
Total Current Liabilities	3.88M	4.28M	7.7M	1.51M	578.38K	2.01M	567.94K	490.22K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	499.81K	n/a	n/a
Other Long-Term Liabilities	737K	13.68M	n/a	n/a	n/a	7.18M	7.08M	6.83M
Total Long-Term Liabilities	737K	13.68M	3.96M	n/a	n/a	7.68M	7.08M	6.83M
Total Liabilities	4.62M	17.96M	7.7M	1.51M	578.38K	9.69M	7.64M	7.32M
Total Debt	n/a	n/a	n/a	n/a	n/a	499.81K	n/a	n/a
Common Stock	1.41K	1.05K	816.00	810.00	689.00	28.00	28.00	27.00
Retained Earnings	-134.85M	-110.26M	-54.05M	-28.73M	-14.24M	-8.78M	-7.79M	-7.07M
Comprehensive Income	n/a	n/a	0.00	0.00	-0.00	-7.08M	-7.08M	-6.83M
Shareholders Equity	9.31M	-7.75M	28.32M	44.49M	7.54M	-8.58M	-7.59M	-6.97M
Total Investments	10.54B	n/a	n/a	n/a	n/a	n/a	n/a	n/a